Evaluation of Quality of Life in Patients with Metabolic Syndrome and Risk of Sleep Apnea Using SF-36 Short Form

1 Tune, J.D.; Goodwill, A.G.; Sassoon, D.J.; Mather, K.J. Cardiovascular consequences of metabolic syndrome. Transl Res 2017, 183, 57-70, doi:10.1016/j.trsl.2017.01. 001. Search in Google Scholar

2 Alidu, H.; Dapare, P.P.M.; Quaye, L.; Amidu, N.; Bani, S.B.; Banyeh, M. Insulin Resistance in relation to Hypertension and Dyslipidaemia among Men Clinically Diagnosed with Type 2 Diabetes. Biomed Res Int 2023, 2023, 8873226, doi:10.1155/2023/8873226. Search in Google Scholar

3 Rus, M.; Crisan, S.; Andronie-Cioara, F.L.; Indries, M.; Marian, P.; Pobirci, O.L.; Ardelean, A.I. Prevalence and Risk Factors of Metabolic Syndrome: A Prospective Study on Cardiovascular Health. Medicina (Kaunas) 2023, 59, doi:10.3390/medicina59101711. Search in Google Scholar

4 Ghitea, T.C.; Vlad, S.; Birle, D.; Tit, D.M.; Lazar, L.; Nistor-Cseppento, C.; Behl, T.; Bungau, S. The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome. Acta Endocrinol (Buchar) 2020, 16, 470-478, doi:10.4183/aeb.2020.470. Search in Google Scholar

5 Poanta, L.I.; Albu, A.; Fodor, D. Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. Med Ultrason 2011, 13, 215-219. Search in Google Scholar

6 Behl, T.; Sehgal, A.; Grover, M.; Singh, S.; Sharma, N.; Bhatia, S.; Al-Harrasi, A.; Aleya, L.; Bungau, S. Uncurtaining the pivotal role of ABC transporters in diabetes mellitus. Environ Sci Pollut Res Int 2021, 28, 41533-41551, doi:10.1007/s11356-021-14675-y. Search in Google Scholar

7 Gheorghe, G.; Toth, P.P.; Bungau, S.; Behl, T.; Ilie, M.; Pantea Stoian, A.; Bratu, O.G.; Bacalbasa, N.; Rus, M.; Diaconu, C.C. Cardiovascular Risk and Statin Therapy Considerations in Women. Diagnostics (Basel) 2020, 10, doi:10.3390/diagnostics10070483. Search in Google Scholar

8 Korson, R.; Guilleminault, C. Obstructive sleep apnea syndrome. Sleep Disorders Medicine: Basic Science, Technical Considerations and Clinical Aspects 2017, 567-596. Search in Google Scholar

9 Drager, L.F.; Jun, J.C.; Polotsky, V.Y. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 2010, 843-851,doi:10.1016/j.beem. 2010.08.011. Search in Google Scholar

10 Mohamed, S.M.; Shalaby, M.A.; El-Shiekh, R.A.; El-Banna, H.A.; Emam, S.R.; Bakr, A.F. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chemistry Advances 2023, 3, doi:https://doi.org/10.1016/j.focha.2023.100335. Search in Google Scholar

11 Liegl, G.; H. Fischer, F.; N. Martin, C.; Rönnefarth, M.; Blumrich, A.; Ahmadi, M.; Boldt, L.-H.; Eckardt, K.-U.; Endres, M.; Edelmann, F. Converting PROMIS®-29 v2. 0 profile data to SF-36 physical and mental component summary scores in patients with cardiovascular disorders. Health and quality of life outcomes 2024, 22, 64. Search in Google Scholar

12 Stavrou, V.T.; Astara, K.; Tourlakopoulos, K.N.; Papayianni, E.; Boutlas, S.; Vavougios, G.D.; Daniil, Z.; Gourgoulianis, K.I. Obstructive Sleep Apnea Syndrome: The Effect of Acute and Chronic Responses of Exercise. Frontiers in Medicine 2021, 8, doi:10.3389/fmed. 2021.806924. Search in Google Scholar

13 dos Santos Fernandes, I.S.; Mendonça, S.M.; Dutra, J.T.; Orsini, M.; Machado, S.; Tavares, M.S.; Moreno, A.M.; Soares, D.C.; Gomçalbes, T.R. Association of Quality of Life and Anxiety Indicators with the Physical Capacity of Elderly: A Crossover Study: Physical Capacity in Elderly. Cuadernos de Psicología delDeporte 2024, 24. Search in Google Scholar

14 Sears, B. Anti-inflammatory diets. Journal of the American College of Nutrition 2015, 34, 14-21. Search in Google Scholar

15 Hernando-Redondo, J.; Toloba, A.; Benaiges, D.; Salas-Salvadó, J.; Martínez-González, M.A.; Corella, D.; Estruch, R.; Tinahones, F.; Ros, E.; Goday, A. Mid-and long-term changes in satiety-related hormones, lipid and glucose metabolism, and inflammation after a Mediterranean diet intervention with the goal of losing weight: A randomized, clinical trial. Frontiers in Nutrition 2022, 9, 950900. Search in Google Scholar

16 Evrensel, A.; Ceylan, M.E. Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clinical psychopharmacology and neuroscience 2016, 14, 231. Search in Google Scholar

17 Aziz, M.N.M.; Kumar, J.; Muhammad Nawawi, K.N.; Raja Ali, R.A.; Mokhtar, N.M. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients 2021, 13, doi:10.3390/nu13093061. Search in Google Scholar

18 Khanna, H.N.; Roy, S.; Shaikh, A.; Bandi, V. Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders. Euroasian J Hepatogastroenterol 2022, 12, 102-108, doi:10.5005/jp-journals-10018-1384. Search in Google Scholar

19 Jain, S.; Banerjee, B.D.; Ahmed, R.S.; Arora, V.K.; Mediratta, P.K. Possible role of oxidative stress and brain derived neurotrophic factor in triazophos induced cognitive impairment in rats. Neurochemical Research 2013, 38, 2136-2147. Search in Google Scholar

20 Nicosia, N.; Giovenzana, M.; Misztak, P.; Mingardi, J.; Musazzi, L. Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders. Int J Mol Sci 2024, 25, doi:10.3390/ijms25126521. Search in Google Scholar

21 Barandouzi, Z.A.; Lee, J.; del Carmen Rosas, M.; Chen, J.; Henderson, W.A.; Starkweather, A.R.; Cong, X.S. Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome. Scientific Reports 2022, 12, 1648, doi:10.1038/s41598-022-05756-0. Search in Google Scholar

22 Romero-Corral, A.; Caples, S.M.; Lopez-Jimenez, F.; Somers, V.K. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 2010, 137, 711-719, doi:10.1378/chest.09-0360. Search in Google Scholar

23 Xu, X.; Xu, J.; Zhang, M. Association between metabolic score for visceral fat and obstructive sleep apnea: a cross-sectional study. Frontiers inMedicine 2024, 11, 1480717. Search in Google Scholar

24 Vgontzas, A.N.; Bixler, E.O.; Chrousos, G.P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005, 9, 211-224, doi:10.1016/j.smrv.2005.01.006. Search in Google Scholar

25 Zou, J.; Wang, Y.; Xu, H.; Xia, Y.; Qian, Y.; Zou, J.; Guan, J.; Chen, B.; Yi, H.; Yin, S. The use of visceral adiposity variables in the prediction of obstructive sleep apnea: evidence from a large cross-sectional study. Sleep and Breathing 2020, 24, 1373-1382. Search in Google Scholar

26 Schlotz, W.; Ambery, P.; Syddall, H.E.; Crozier, S.R.; Sayer, A.A.; Cooper, C.; Phillips, D.I.; Group, H.C.S. Specific associations of insulin resistance with impaired healthrelated quality of life in the Hertfordshire Cohort Study. Quality of Life Research 2007, 16, 429-436. Search in Google Scholar

27 Iftikhar, I.H.; Donley, M.A.; Mindel, J.; Pleister, A.; Soriano, S.; Magalang, U.J. Sleep duration and metabolic syndrome. An updated dose–risk meta-analysis. Annals of the American Thoracic Society 2015, 12, 1364-1372. Search in Google Scholar

28 Shuster, A.; Patlas, M.; Pinthus, J.; Mourtzakis, M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. The British journal of radiology 2012, 85, 1-10. Search in Google Scholar

29 Iftikhar, I.H.; Donley, M.A.; Mindel, J.; Pleister, A.; Soriano, S.; Magalang, U.J. Sleep duration and metabolic syndrome. An updated dose–risk meta-analysis. Annals of the American Thoracic Society 2015, 12, 1364-1372. Search in Google Scholar

30 Kho, Z.Y.; Lal, S.K. The human gut microbiome–a potential controller of wellness and disease. Frontiers in microbiology 2018, 9, 1835. Search in Google Scholar